Device / Technology News

RSS

Critical Diagnostics signs agreements with four new European distributors

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that it has signed agreements with four new European distributors in Germany, Spain, France and Turkey.

15 Oct 2012

Bruker launches robust ContourGT-I 3D Optical Microscope

Bruker announced the launch today of the ContourGT-I 3D Optical Microscope to enhance R&D productivity and maximize manufacturing throughput for industrial applications. The ContourGT-I has been optimized to accelerate and simplify measurement setup and feature-tracking and is the world's first bench top profiling system to incorporate Bruker's proprietary tip/tilt head design, along with fully automated functionality, including turret, lenses, and illumination.

From Bruker Nano Surfaces and Metrology 15 Oct 2012

Abertay lecture to reveal how computer games can help discover new drugs for cancer

How can computer games technology help discover new drugs to treat cancer? This surprising step forward for science will be revealed at a free public lecture at the University of Abertay Dundee this Wednesday at 6pm.

15 Oct 2012

Researchers develop two ultra-rapid tests for diagnosis of antibiotic resistance

With their excellent sensitivity and specificity, the use of these extremely efficient tests on a world-wide scale would allow us to adapt antibiotic treatments to the individual's needs and to be more successful in controlling antibiotic resistance, particularly in hospitals.

15 Oct 2012

AXA PPP healthcare introduces new Facebook app for cancer patients

AXA PPP healthcare has launched a new Facebook application - little big things - for people affected by cancer to share inspirational tips and practical information on coping with the disease and its treatment.

15 Oct 2012

Study evaluates international data on kidney transplantation

Kidney transplants performed in Europe are considerably more successful in the long run than those performed in the United States.

15 Oct 2012

Database of drug-induced liver injury now available from NIH

A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available from the National Institutes of Health. Researchers and health care professionals can use the LiverTox database to identify basic and clinical research questions to be answered and to chart optimal ways to diagnose and control drug-induced liver injury.

15 Oct 2012

Capitol Hill fights over health law, EHR doc payments continue

Lawmakers on Capitol Hill sound off on the Obama administration's "meaningful use" payments to doctors as the fight over parts of the health law -- its oversight and D.C's insurance exchange -- continue.

15 Oct 2012

Elekta Synergy system with Agility 160-leaf MLC now available at Radboud

The first of three newly acquired Elekta Synergy treatment systems equipped with Agility 160-leaf multi-leaf collimator (MLC) is now up and running clinically at Radboud University Nijmegen Medical Center - making the clinic the first in the Netherlands to use Agility.

From Elekta 15 Oct 2012

Treatment of OSA could reduce blood pressure in men with hypertension

A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.

15 Oct 2012

Duke researchers develop new 3-D tool for heart surgery

A team of researchers from Duke University speaking at the ANESTHESIOLOGY 2012 annual meeting revealed the development of a new 3-D tool that enables trainees in transesophageal echocardiography (TEE) to have real-time instruction in obtaining and interpreting high-quality images of the heart and major vessels - and it's all just a finger swipe away on your Apple iPad.

15 Oct 2012

Cellectricon settles patent infringement litigation with Fluxion

Cellectricon AB and Fluxion Biosciences today announced that they have settled the patent infringement litigation that Cellectricon commenced against Fluxion in 2009.

From Fluxion Biosciences 15 Oct 2012

BC Cancer Agency second prestigious Vancouver institution to install MILabs Molecular Imaging System

MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.

12 Oct 2012

Queen's chemists devise novel technique for rapid production of MOF porous materials

Chemists at Queen's University Belfast have devised a novel, environmentally friendly technique, which allows the rapid production of Metal-Organic Frameworks porous materials (MOFs).

12 Oct 2012

AIUM to host Ultrasound First Forum on Nov. 12

The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.

12 Oct 2012

ZELTIQ Aesthetics’ CoolCurve+ applicator to be highlighted at EMAA 2012

ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the 8th European Masters in Aesthetics & Anti-Aging (EMAA) in Paris, October 12-14, 2012, and will highlight CoolCurve+, the newest addition to the applicator platform for the CoolSculpting System.

12 Oct 2012

Johns Hopkins, Iverson enter licensing agreement for molecular diagnostics

Iverson Genetic Diagnostics, Inc. announced today an exclusive licensing agreement with Johns Hopkins University School of Medicine under which Iverson receives global exclusive commercialization rights for molecular diagnostics that are designed to help physicians to assess cardiovascular risk in men and women and infertility risk in women.

12 Oct 2012

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).

12 Oct 2012

Brain scans can identify reading skills of children

If a 7-year-old is breezing through the "Harry Potter" books, studies indicate that he or she will be a strong reader later in life. Conversely, if a 7-year-old is struggling with "The Cat in the Hat," that child will most likely struggle with reading going forward.

12 Oct 2012

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus BioSciences, Inc., a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today announced that it has acquired an exclusive option to license the LymPro Alzheimer's Diagnostic Blood Test from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, LLC.

11 Oct 2012